期刊文献+

肺硬化性血管瘤的临床病理特点 被引量:1

Clinicopathological Characteristics of Sclerosing Hemangioma of the Lung
暂未订购
导出
摘要 目的:探讨肺硬化性血管瘤的临床病理特点及组织来源。方法:对4例肺硬化性血管瘤进行临床病理、免疫组化研究。结果:肺硬化性血管瘤由实性片块区、乳头区、血管瘤样区及硬化区组成。被覆乳头表面、实性区裂隙及血管样腔面的立方细胞;实性区及乳头轴心为形态一致的圆形、多边形胞浆浅染细胞。免疫组化示:两种细胞均表达TTF-1,立方细胞表达CK、EMA;而浅染圆形细胞弥漫表达Vi mentin、ER、PR,部分表达NSE和Syn。结论:肺硬化性血管瘤可能起源于肺泡Ⅱ型细胞或呼吸道的原始的多潜能干细胞。ER、PR的高表达可能与女性的高发病率密切相关。 Objective To study the clinicopathological characteristics and histogenesis of sclerosing hemangioma of the lung (SHL). Methods Four cases of SHL were investigeted by light microscopy and immunohistochemistry. Results The tumor showed a mixture of the following four histological patterns, solid, papillary,hemangioma-like and sclerotic. Cuboidal cells covered the papillary projections and cleft-slide spaces in solid areas whereas solid areas and the stalk of papillary projections were composed of uniform,round or polygonal pale cells. Immunohistochemistry staining revealed that the surface of the cuboidal cells expressed TTF-1,CK, EMA,and the round .pale cells expressed TTF-1, vimentin, ER and PR,some NSE,Syn. Conclusion SHL may originate from the pulmonary alveolar Ⅱ cell or primitive respiratory multipotent stem cell. Expression of ER,PR correlates with predisposition of this tumor to women.
出处 《实用医技杂志》 2006年第4期528-529,共2页 Journal of Practical Medical Techniques
关键词 硬化性血管瘤 临床病理学 免疫组织化学 TTF-1 Lung Sclerosing hemangioma Clinicopathology Immunohistochemistry TTF- 1
  • 相关文献

参考文献3

二级参考文献21

  • 1张宝麟,战忠利.肺炎性假瘤和癌的关系[J].中国肿瘤临床,1993,20(1):47-48. 被引量:10
  • 2李维华,许红民,李红芬,于占洋,王淑琴,李志军,赵武宪.肺的一种良性神经内分泌肿瘤──对所谓肺硬化性血管瘤来源的探讨[J].中华病理学杂志,1994,23(2):69-72. 被引量:72
  • 3Xu HM,Li WH,Hou N, et al. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study. Am J Surg Pathol,1997,21:1013-1022.
  • 4Katzenstein AL,Gmelich JT,Carrington CB. Sclerosing hemangioma of The lung: a clinicopathologic study of 51 cases. Am J Surg Pathol,1980,4:343-356.
  • 5Yousem SA, Wlck MR,Singh G,et al.So-called sclerosing hemangioma of Lung. An immunohistochemical study supporting a respiratory epithelial origin. Am J Surg Pathol,1988,12:582-590.
  • 6Stahlman MT,Gray ME,Whitsett JA. Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J Histochem Cytochem, 1996,44:673-678.
  • 7Kaufmann O,Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology,2000,36:8-16.
  • 8Niho S,Suzuki K,Yokose T,et al.Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol,1998,152:1065-1069.
  • 9Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, et al . A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies. TTF-1 is expressed in both round and surface cells,sugesting an origin from primitive respiratory epithelium. Am J Surg Pathol,2000,24:906-916.
  • 10Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1(TTF-1). Am J Surg Pathol, 2000, 24:1531-1536.

共引文献79

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部